Bunkyo, Japan

Kieko Hara

This inventor holds 1 USPTO granted patent. Top assignees: Juntendo Educational Foundation, Riken Corporation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kieko Hara. Retrieved from https://idiyas.com/inventor/kieko-hara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kieko Hara: Innovator in Lung Cancer Diagnosis

Introduction

Kieko Hara is a notable inventor based in Bunkyo-ku, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the differentiation of lung cancer types. His innovative approach has the potential to enhance the accuracy of lung cancer diagnoses.

Latest Patents

Kieko Hara holds a patent for a method that differentiates between lung squamous cell carcinoma and lung adenocarcinoma. This patent provides an approach for differentially determining the histological type of a lung cancer lesion objectively and rapidly with high accuracy. The method involves measuring the expression level of a DNA product in a biological sample collected from the lesion. This innovative technique aims to improve the assessment of lung cancer lesions, allowing for more precise treatment options.

Career Highlights

Throughout his career, Kieko Hara has worked with esteemed organizations such as the Juntendo Educational Foundation and Riken Corporation. His experience in these institutions has contributed to his expertise in cancer research and diagnostics.

Collaborations

Kieko Hara has collaborated with notable colleagues, including Kazuya Takamochi and Kenji Suzuki. These partnerships have fostered advancements in the field of lung cancer research.

Conclusion

Kieko Hara's contributions to lung cancer diagnostics through his innovative patent demonstrate his commitment to improving medical outcomes. His work continues to influence the field and offers hope for more accurate cancer diagnoses in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…